An unusual case of idiopathic inflammatory myopathy presenting with organizing pneumonia as cavitary lesions by Agrawal, Sumita et al.
CASE REPORTS
243www.journals.viamedica.pl
Address for correspondence: Jagdish Chander Suri, Medeor JCS Institute of Pulmonary, Critical Care & Sleep Medicine, 33–34 Qutab Institutional Area, 110016 New Delhi, India; 
e-mail: docjcsuri@gmail.com
DOI: 10.5603/ARM.2019.0041
Received: 28.01.2019
Copyright © 2019 PTChP
ISSN 2451–4934
Sumita Agrawal1, Nitesh Gupta1, Rohit Kumar1, M. K. Sen1, Shibdas Chakrabarti1, Jagdish Chander Suri2
1Department of Pulmonary, Critical Care & Sleep Medicine, VMMC & Safdarjung Hospital, New Delhi, India
2Medeor JCS Institute of Pulmonary, Critical Care & Sleep Medicine, Qutab Institutional Area, New Delhi, India
An unusual case of idiopathic inflammatory myopathy presenting 
with organizing pneumonia as cavitary lesions
Abstract
A young woman presented with gradually progressive breathlessness, cough and muscle weakness for one and a half year. Her 
chest radiograph showed multiple, bilateral thin-walled cavitary lesions. Her serum was found to be positive for anti-Jo1 anti-
bodies on serology. Histopathology of lung lesions was suggestive of organizing pneumonia. The muscle biopsy demonstrated 
a myopathic pattern. On the basis of these findings she was diagnosed to be the case of idiopathic inflammatory myopathy. Her 
condition improved significantly after treatment with steroids.
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Introduction
Inflammatory idiopathic myopathies (IIM) 
are a group of uncommon autoimmune disorders 
[1]. The clinical presentation includes proximal 
skeletal muscle weakness, raised muscle enzy-
mes (e.g. creatine kinase, CK) and extramuscular 
organ involvement, most frequently the lungs, 
resulting in interstitial lung disease (ILD). Orga-
nizing pneumonia is a rare form of ILD in IIM. 
Here, we present an unusual case of idiopathic 
inflammatory myopathy presenting with organi-
zing pneumonia as cavitary lesions.
Material and methods
A  38-year-old housewife presented with 
breathlessness associated with dry cough and 
low-grade, intermittent fever. The breathlessness 
gradually progressed from mMRC grade 1 to grade 
4, over a period of one and half years. There were 
no complaints indicative of a connective tissue 
disorder such as joint pain, Raynaud’s phenome-
non, skin rash, photosensitivity, dryness of the 
eyes or mouth, loss of appetite or weight. She 
denied any exposure to tobacco smoke, drugs (like 
nitrofurantoin, methotrexate, bleomycin etc.) or 
having pets in the house. There was no past hi-
story of similar complaints. Family history of any 
significant illness could not have been elicited.
On physical examination she was conscious, 
cooperative, and well oriented to time and place. 
Her pulse rate was 126/min, regular; respiratory 
rate was 24/min and oxygen saturation was 88% 
while breathing room air. An erythematous and 
itchy rash was also observed over the face about 
which patient had not complained initially (Fi-
gure 1). On auscultation of the chest, bilateral 
end-inspiratory crackles were heard. Chest X-ray 
demonstrated cyst-like opacities in the left lower 
zone (Figure 2). Computed tomography scan of 
the chest showed bilaterally multiple, round to 
irregular, thin-walled cavities, which were in 
communication with the segmental bronchi. Cen-
trilobular nodules with a tree-in-bud pattern were 
also observed in the posterior segment of the right 
upper lobe, lateral segment of the middle lobe, 
superior segment of the right lower lobe and all 
segments of the left lower lobe. No significant me-
diastinal or hilar lymphadenopathy was noticed 
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Figure 1. Bilateral malar rash
Figure 2. Chest X-ray (PA view) showing cavitary lesions in the left 
lower zone
Figure 3. Computed tomography scan showing bilateral cavitary lesion
(Figure 3). Her arterial blood gas analysis was sug-
gestive of hypoxic respiratory failure with wide 
alveolar-arterial oxygen gradient and respiratory 
alkalosis. The hemoglobin, total and differential 
leucocyte counts, liver and renal function tests 
were within normal limits. Spirometry suggested 
a mixed obstructive and restrictive ventilatory 
pattern with values of FEV1/FVC 71.19% (less 
than lower limit of normal), FVC 1.92 L (62% of 
predicted value) and FEV1 1.37 L (52% of pre-
dicted value). Examination of both sputum and 
bronchoalveolar lavage (BAL) fluid was negative 
for acid-fast bacilli (AFB) on direct smear and 
culture. The cartridge-based nucleic acid am-
plification test (CB-NAAT) was also negative for 
tuberculosis (Xpert MTB/RIF). No atypical cells 
were seen. Although it is known that in DPLD, 
histological support for a specific diagnosis can 
be obtained using transbronchial lung biopsy 
(TBLB) in 29–79% of cases only [2], since we do 
not have facilities for surgical lung biopsy in our 
set-up, we went ahead with transbronchial lung 
biopsy. This was done with the intent that if TBLB 
is negative then we will shift the patient to a cen-
ter where such facility is available. The histopa-
thology of transbronchial lung biopsy specimen 
demonstrated a moderate interstitial lymphoid 
infiltrate with organizing pattern of nodules and 
remodeling near bronchovascular regions. The 
nodules had spindle cells having myxoid stroma 
in the form of intra-alveolar buds and without any 
evidence of granuloma formation, atypical cells 
or fungal organisms consistent with organizing 
pneumonia. This pathology finding was confir-
med by two pathologists independently. Based on 
these initial clinical and laboratory parameters, 
we arrived at the diagnosis of organizing pneumo-
nia with multiple cavitary lesions. 
In order to differentiate it from idiopathic or-
ganizing pneumonia and find a secondary cause, 
meticulous history and systemic examination was 
performed. On detailed probing, the patient repor-
ted that she had experienced difficulty in getting 
up from the squatting position and also while 
combing her hair for about a week. On physical 
examination, there was bilateral proximal muscle 
weakness in the upper and lower limbs (motor 
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power of 4/5, normal muscular tone), with normal 
deep tendon reflexes and sensory system. Electro-
myography (EMG) and nerve conduction velocity 
(NCV) studies were suggestive of a myopathic pat-
tern. The level of serum creatinine phosphokinase 
(CPK) was elevated to 700 U/L (normal 38–176 U/L 
in females). Anti-Jo-1 antibody test was positive, 
suggesting an inflammatory myopathy. Other au-
toimmune markers like anti-nuclear antibodies 
(ANA), anti-ds DNA, anti-Ro52 recombinant, anti
-SS-B antibody, anti-U1-RNP/Sm, anti-La antibody, 
anti-cardiolipin antibody, rheumatoid factor and 
anti-CCP antibody, anti-phospholipid antibodies 
(APLA), were negative. The direct Coombs’ test was 
also negative. Complement C3 level was 87 mg/dL 
(normal range 90–180 mg/dL), and C4 level was 
21 mg/dL (normal range 15–57 mg/dL). Muscle biop-
sy showed the presence of endomysial inflammation. 
The history of muscle weakness, laboratory 
measurements of CPK and anti-Jo1 antibody along 
with the muscle biopsy report were consistent 
with the diagnosis of idiopathic inflammatory 
myopathy with polymyositis. This was in accor-
dance with the American College of Rheumato-
logy and European League Against Rheumatism 
(ACR/EULAR) diagnostic criteria for adult and 
juvenile idiopathic inflammatory myopathies 
and their major subgroups 2017 [1]. She was sub-
sequently treated with oral prednisolone (1 mg/kg 
body weight) for a period of four weeks. A follo-
w-up visit after 4 weeks showed clinical impro-
vement in her symptoms, ABG and CPK levels. 
Discussion
Organizing pneumonia is a rare lung disease 
that is characterized by an inflammatory involve-
ment of bronchioles and alveoli, which responds 
very well to corticosteroids. It usually presents 
with a subacute course of fever or flu-like illness 
associated with cough, weight loss and mild dysp-
nea. It is defined histopathologically by the pre-
sence of intra-alveolar buds of granulation tissue 
consisting of an admixture of myofibroblasts and 
connective tissue [3]. It has been reported to occur 
in association with a variety of conditions like: 
infection (lung abscess, necrotizing pneumonia, 
septic pulmonary emboli, fungal infections, 
parasitic diseases, viral infection), malignancy 
(primary lung cancer, most commonly squamous 
cell carcinoma, others being primary or secondary 
pulmonary lymphoma, pulmonary metastases), 
others being rheumatoid nodules developing 
central necrosis, granulomatosis with polyangiitis 
(GPA), ankylosing spondylitis, primary pulmona-
ry amyloidosis, eosinophilic granulomatosis with 
polyangiitis, sarcoidosis and systemic lupus ery-
thematosus. It may be termed as idiopathic in case 
no causative factor is identified [4]. Our patient’s 
BAL fluid for infectious causes was negative, no 
malignant cells were seen. She had Anti-Jo-1 Ab-
-positive, and TBLB was suggestive of organizing 
pneumonia. This antibody is positive in cases of 
idiopathic inflammatory myopathy (IIM) which 
is a group of immune-mediated disorders that 
are sub-categorized into polymyositis (PM), der-
matomyositis (DM) and inclusion body myositis 
(IBM) [5]. These disorders can be associated with 
a  range of myositis-specific auto-antibodies to 
aminoacyl t-RNA synthetases, signal recognition 
particles and nuclear helicase Mi-2. The patient 
described in the report had anti-Jo-1 antibodies 
directed against the anti-histidyl-tRNA syntheta-
se. This antibody is usually detectable in 15–30% 
of myositis patients and more often in the polymy-
ositis ones [5]. Idiopathic inflammatory myopathy 
is a  relatively rare disorder with prevalence of 
0.5–8.4 cases per million population [6].
Interstitial lung disease (ILD) has been re-
ported in 20–80% of cases of IIM [7–10]. Various 
forms of ILD have been described, including 
non-specific interstitial pneumonitis (NSIP), 
usual interstitial pneumonia (UIP), organizing 
pneumonia and diffuse alveolar damage (DAD). 
Organizing pneumonia is a  rare form of ILD 
in IIM. In the two case series of IIM, ILD was 
reported to be present in 2 out of 36 patients 
in the first [11] and 1 out of 22 patients in the 
second case series [12]. Organizing pneumonia 
can present with varied radiological features. 
The radiological features described in various 
reports are focal lesion, nodules, bronchocentric 
picture, linear band-like shadows, perilobular 
lesions, cavitary and ring-like shadows, and 
progressive fibrotic opacities [13]. Mehrian et al. 
have reported that HRCT features like lower lobe 
pneumonia, sub-pleural reticulation, non-septal 
linear opacities, bronchial dilatation and reverse 
halo sign were more likely to occur in organizing 
pneumonia [14]. The unusual findings of organi-
zing pneumonia presenting as cavitary lesions in 
our case have also been reported in three other 
case reports [15–17]. Organizing pneumonia was 
confirmed by surgical biopsy in these cases. It 
has been suggested that pathogenesis of a cavity 
formation in these cases could be as a consequen-
ce of inflammatory injury to the lung with focal 
areas of necrosis within organizing pneumonia 
[3]. Additionally, it may be likely that some of 
these cavities are secondary to pneumatoceles.
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Conclusion
Our patient presented with an uncommon 
manifestation of cavitary form of organizing 
pneumonia that was secondary to an inflamma-
tory disorder. Also, the symptoms of her primary 
disorder presented much later than the ILD. 
This rare presentation underscores the impor-
tance of a  thorough evaluation of any cavitary 
lesion before labelling it as idiopathic organizing 
pneumonia.
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